Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation
Open accessThe DOI matches its Crossref record.
Abstract
It can be shown that over 94% of COVID-19 superspreading events occurred in limited ventilation areas suggesting aerosolized transmission is a strong contributor to COVID-19 infections. This study helps answer “How long may a person safely remain within various environments?” And “What exposure levels could result in immunity without becoming ill via asymptomatic graduated inoculation?” COVID-19 infection likelihood, symptom severity, and immune response dependencies include viral load exposure amount. A better understanding of these relationships could help determine what Non-Pharmaceutical Interventions (NPI) would help reduce severe case counts and improve at-large epidemiologic responses in specific scenarios. This study references peer reviewed and published studies and uses them as data sources for an estimation model that calculates infection likelihood given exposure within several example scenarios. Information from ASHRAE office ventilation standards, typical home ventilation characteristics, and an outdoor air setting are used to establish several specific examples of indoor and outdoor scenarios. The model establishes a reference scenario using objectively measured air sample viral load concentration levels found within a carefully documented hospital environment containing 2 sick patients. The model extrapolates the reference scenario into several example scenarios that have varied exposure time duration, ventilation amount, with/without surgical mask use, activity/respiration levels, and infected subject shedding levels. It uses the reference data and scenario extrapolations to calculate an estimate of total viral load exposure dose for each scenario. The study then interprets the various scenario total exposure dose estimates using an National Institute of Health human challenge study where volunteers were exposed to multiple specific viral quantities and observed in a clinical environment to objectively determine likelihood of infection, severity level, and immune response given each specific exposure dose. To simplify pragmatic use of the results, each example scenario presents the estimated total exposure dose alongside an intuitive severity category of Not Ill, Minor Illness, Clinical Mild Illness, and Possible Severe Illness which are based on a defined interpretation of the NIH study results. Immune response data related to these categories is also provided along with discussion related to asymptomatic infection, graduated inoculation, and immunity. When appropriately interpreted for individualized applications, the estimates herein could contribute to guidance for those at low-risk for a severe case that have no obvious COVID-19 co-morbidities, with the understanding that those at higher risk should seek to avoid all exposure risk. The estimates herein may help efforts to strike a balance in developing holistic epidemiologic interventions that consider the effects of these interventions on economic, civic, social, and mental health, which have pathologies within their own realms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
Mossong, J., Hens, N., Jit, M., Beutels, P., Auranen, K., Mikolajczyk, R., Massari, M., Salmaso, S., Tomba, G. S., Wallinga, J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050074 · Cited by 2,900
“Preparing for outbreaks of directly transmitted pathogens such as pandemic influenza [1] [2] [3] and SARS [4] [5] [6] [7] [8] [9] , and controlling endemic diseases such as tuberculosis and meningococcal diseases, are major public health priorities.”
BackgroundSelf-citationNonpharmaceutical Interventions for Pandemic Influenza, International Measures
World Health Organization Writing Group (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.051370 · Cited by 326
Quilty, B. J., Clifford, S., group2, C. N. W., Flasche, S., & Eggo, R. M. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.5.2000080 · Cited by 321
“Despite limited evidence for its effectiveness, airport screening has been previously implemented during the 2003 SARS epidemic and 2009 influenza A(H1N1) pandemic to limit the probability of infected cases entering other countries or regions [5-7].”
BackgroundThe economic impact of SARS: How does the reality match the predictions?
Keogh-Brown, M. R., & Smith, R. D. (2008) · Health Policy · doi:10.1016/j.healthpol.2008.03.003 · Cited by 311
Delaying the International Spread of Pandemic Influenza
Cooper, B. S., Pitman, R. J., Edmunds, W. J., & Gay, N. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030212 · Cited by 305
Self-citation
Metadata
- Authors
- Pitman, R. J., Cooper, B. S., Trotter, C. L., Gay, N. J., & Edmunds, W. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2005-09-21
- Volume
- 331
- Issue
- 7527
- Pages
- 1242.2-1243
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2081028562
- Cited by
- 90
- References
- 0
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. https://app.cochat.ai/papers/10.1136/bmj.38573.696100.3a
- The paper
- Pitman, R. J., Cooper, B. S., Trotter, C. L., Gay, N. J., & Edmunds, W. J. (2005). Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ. https://doi.org/10.1136/bmj.38573.696100.3a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.